| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/09/2001 | WO2001057073A2 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 08/09/2001 | WO2001056600A1 Method of controlling the qualities of attenuated pox vaccine |
| 08/09/2001 | WO2001056599A2 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/09/2001 | WO2000077216A3 Porcine circovirus vaccine in recombinant poxvirus |
| 08/09/2001 | US20010012610 Of biological specimens by true vitrification comprising dehydrating a biologically active material at a temperature higher than the suggested storage temperatures followed by cooling of the sample to the storage temperature |
| 08/09/2001 | US20010012516 Viral vectors |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/09/2001 | CA2398915A1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/08/2001 | EP1122306A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 08/08/2001 | EP1121442A2 Recombinant e1a deleted adenoviral vectors |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121420A2 Hepatitis a vaccines |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | CN1307102A Rcombinant adenovirus and its use in preventing and treating fibrous diseases |
| 08/08/2001 | CN1069216C Process for production of attenuated varicella zoster virus vaccine |
| 08/07/2001 | US6271014 A polypeptide with proteolytic activity; therapy for periodontal disease, rheumatoid arthritis, aging, cancer, wound healing, bone resorption, pregnancy and parturition |
| 08/07/2001 | US6270996 Enhancing conversion of single stranded adeno-associated virus to double stranded; infecting target cells with the recombinant virus and exposing the infected cells to an agent; gene therapy cancer and cystic fibrosis |
| 08/07/2001 | US6270975 Nucleotide sequences for use in the diagnosis of viral infection |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055362A2 Hybrid adeno-retroviral vector for the transfection of cells |
| 08/02/2001 | WO2001055361A2 Recombinant aav packaging systems |
| 08/02/2001 | WO2001055354A1 Methods for inactivating viruses |
| 08/02/2001 | WO2001055353A2 Recombinant attenuation of prrsv |
| 08/02/2001 | WO2001055330A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001005950A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | WO2001002592A9 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 08/02/2001 | WO2001000234A3 Methods and compositions for engineering of attenuated vaccines |
| 08/02/2001 | US20010010900 Transducing phages |
| 08/02/2001 | US20010010816 Purified FIV-141 virus; vaccines |
| 08/02/2001 | EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | DE10003373A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003372A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003371A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | CA2397532A1 Recombinant aav packaging systems |
| 08/02/2001 | CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | CA2396454A1 Recombinant attenuation of prrsv |
| 08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/01/2001 | EP1119627A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/01/2001 | EP1119626A2 Botulinum neurotoxin vaccine |
| 08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
| 08/01/2001 | EP1119616A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306574A Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same |
| 08/01/2001 | CN1306090A Low-virulent vaccine K genom sequence of tomato mosaic |
| 07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
| 07/31/2001 | US6268213 Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| 07/31/2001 | US6268178 Phage-dependent super-production of biologically active protein and peptides |
| 07/31/2001 | US6268123 Extraction, measurement; infection diagnosis |
| 07/31/2001 | US6267967 Virus preparations and methods |
| 07/31/2001 | CA2161136C Adenoviruses having modified fiber proteins |
| 07/26/2001 | WO2001053507A1 Replication competent herpes virus strains |
| 07/26/2001 | WO2001053506A2 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | WO2001053505A2 Herpes virus strains for gene therapy |
| 07/26/2001 | WO2001053504A1 Replication deficient adenovirus vectors |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001052887A2 Vaccination against canine herpesvirus infection and vaccines |
| 07/26/2001 | WO2000061613A9 Channel forming toxins as antiviral agents |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009759 Using virus-binding particles having a diameter of 0.05-300m and having either a cationic or anionic group on their surface; simultaneous and simple of large number of species; nucleic acid-amplification |
| 07/26/2001 | US20010009669 Inactive flavivirus such as tick-born encephalitis (TBE) virus, an immunogenic component bonded to the flavivirus or adsorbed therewith |
| 07/26/2001 | CA2398842A1 Replication deficient adenovirus vectors |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2397861A1 Vaccination against canine herpesvirosis and vaccines therefor |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1117777A2 Shuffling of codon altered genes |
| 07/24/2001 | US6265376 Insecticidal plectoxins from plectreurys tristis |
| 07/24/2001 | US6265200 HIV-3 retrovirus and its use |
| 07/24/2001 | US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide |
| 07/24/2001 | US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins |
| 07/24/2001 | US6265149 Screening sample for preferential immunological complexes; incubate sample with antigen, incubate sample with control, monitor complexes formed, count complexes in samples, more complexes in antigen sample indicates presence of retrovirus |
| 07/24/2001 | US6264957 Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 07/19/2001 | WO2001051606A2 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | WO2001051066A2 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | WO2001051027A2 Polymer blends as biodegradable matrices for preparing biocomposites |
| 07/19/2001 | WO2001050872A2 Method for produce sanitation using bacteriophages |
| 07/19/2001 | WO2001050866A2 Method and device for sanitation using bacteriophages |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | US20010008905 Administering a compound such as hydroxyurea to deplete the intracellular pool of deoxyribonucleoside phosphate |
| 07/19/2001 | DE10001390A1 Zelllinie zur Herstellung und Produktion von Schafadenovirusvektoren Cell line for the manufacture and production of Schafadenovirusvektoren |
| 07/19/2001 | CA2430501A1 Method for produce sanitation using bacteriophages |
| 07/19/2001 | CA2430500A1 Method and device for sanitation using bacteriophages |
| 07/19/2001 | CA2430498A1 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | CA2397003A1 Cell line for preparing and producing ovine adenovirus vectors |
| 07/18/2001 | EP1115889A1 Methods to selectively inactivate viruses in biological compositions |
| 07/18/2001 | EP1115880A2 Methods for large-scale production of recombinant aav vectors |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115290A1 Gene delivery system and methods of use |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |